Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 14, 2024

Total Value ($000): $155,011 (100.0% shares, 0.0% debt)

Holdings (11)

NUVB Nuvation Bio 33.0%

Value ($000) $51,223 Shares 14,072,340 Est. Cost $11.18 Unrealized -82.8%

LXEO Lexeo Therapeutics 23.8%

Value ($000) $36,941 Shares 2,355,904 Est. Cost $12.69 Unrealized +23.2%

REPL Replimune Group 15.8%

Value ($000) $24,521 Shares 3,001,319 Est. Cost $17.40 Unrealized -52.9%

ENGN enGene Holdings Inc. 11.8%

Value ($000) $18,244 Shares 1,076,357 Est. Cost $10.40 Unrealized +17.7%

SANA Sana Biotechnology, Inc. 5.4%

Value ($000) $8,438 Shares 843,750 Est. Cost $32.56 Unrealized -77.0%

— Morphic Holding 3.6%

Value ($000) $5,627 Shares 159,846 Est. Cost $19.82 Unrealized —

— Ikena Oncology 2.1%

Value ($000) $3,194 Shares 2,249,123 Est. Cost $28.25 Unrealized —

IMUX Immunic Inc 1.5%

Value ($000) $2,360 Shares 1,788,160 Est. Cost $13.89 Unrealized -90.7%

ENGNW enGene Holdings Inc. 1.2%

Value ($000) $1,877 Shares 360,903 Est. Cost $0.85 Unrealized —

SYRS Syros Pharmaceuticals 0.9%

Value ($000) $1,344 Shares 251,270 Est. Cost $8.12 Unrealized -14.9%

— Kronos Bio 0.8%

Value ($000) $1,243 Shares 955,866 Est. Cost $29.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	14,072,340	$51,223	33.0%	$11.18	-82.8%	Common Stock Class A	67080N101
LXEO	Lexeo Therapeutics	2,355,904	$36,941	23.8%	$12.69	+23.2%	Common Stock	52886X107
REPL	Replimune Group	3,001,319	$24,521	15.8%	$17.40	-52.9%	Common Stock	76029N106
ENGN	enGene Holdings Inc.	1,076,357	$18,244	11.8%	$10.40	+17.7%	Common Stock	29286M105
SANA	Sana Biotechnology, Inc.	843,750	$8,438	5.4%	$32.56	-77.0%	Common Stock	799566104
—	Morphic Holding	159,846	$5,627	3.6%	$19.82	—	Common Stock	61775R105
—	Ikena Oncology	2,249,123	$3,194	2.1%	$28.25	—	Common Stock	45175G108
IMUX	Immunic Inc	1,788,160	$2,360	1.5%	$13.89	-90.7%	Common Stock	4525EP101
ENGNW	enGene Holdings Inc.	360,903	$1,877	1.2%	$0.85	—	Warrant	29286M113
SYRS	Syros Pharmaceuticals	251,270	$1,344	0.9%	$8.12	-14.9%	Common Stock	87184Q206
—	Kronos Bio	955,866	$1,243	0.8%	$29.87	—	Common Stock	50107A104